Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer
Non-small cell lung cancer (NSCLC) patients with sensitizing mutations in the exons 18–21
of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR …
of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR …
Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer.
Z Bakhtiary, J Barar, A Aghanejad, AA Saei… - Drug Development …, 2017 - europepmc.org
Non-small cell lung cancer (NSCLC) patients with sensitizing mutations in the exons 18-21
of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR …
of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR …
Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer
Z Bakhtiary, J Barar, A Aghanejad… - Drug development …, 2017 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) patients with sensitizing mutations in the exons 18-21
of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR …
of the epithelial growth factor receptor (EGFR) gene show increased kinase activity of EGFR …